Clinical trial
An Observational Study of VYKAT™ XR (Diazoxide Choline Extended-Release Tablets) in Patients With Prader-Willi Syndrome (PWS)
NCT07450664 is registered in ClinicalTrials.gov with Soleno Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of VYKAT™ XR (Diazoxide Choline Extended-Release Tablets) in Patients With Prader-Willi Syndrome (PWS)
- Lead sponsor
- Soleno Therapeutics, Inc.
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- November 26, 2025
- Completion date
- March 2, 2028
- Enrollment
- 200 (estimated)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.